Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1889 1
1931 2
1953 3
1954 1
1958 1
1967 1
1969 1
1970 2
1971 1
1977 2
1978 2
1979 1
1984 1
1985 1
1986 2
1988 1
1989 3
1990 3
1991 2
1992 2
1993 6
1994 4
1995 3
1996 4
1997 2
1998 4
2000 7
2001 1
2002 4
2003 1
2004 4
2005 2
2006 1
2008 4
2009 3
2010 3
2011 2
2012 1
2014 2
2016 1
2019 2
2020 1
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

98 results
Results by year
Filters applied: . Clear all
Page 1
Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis.
Levinson K, Beavis AL, Purdy C, Rositch AF, Viswanathan A, Wolfson AH, Kelly MG, Tewari KS, McNally L, Guntupalli SR, Ragab O, Lee YC, Miller DS, Huh WK, Wilkinson KJ, Spirtos NM, Van Le L, Casablanca Y, Holman LL, Waggoner SE, Fader AN. Levinson K, et al. Among authors: purdy c. Gynecol Oncol. 2021 Sep;162(3):532-538. doi: 10.1016/j.ygyno.2021.06.017. Epub 2021 Jul 1. Gynecol Oncol. 2021. PMID: 34217544 Free PMC article.
Cyclophosphamide anaphylaxis.
Jones JB, Purdy CY, Bailey RT Jr. Jones JB, et al. Among authors: purdy cy. DICP. 1989 Jan;23(1):88-9. doi: 10.1177/106002808902300125. DICP. 1989. PMID: 2718490 No abstract available.
Hypothalamic mTORC2 is essential for metabolic health and longevity.
Chellappa K, Brinkman JA, Mukherjee S, Morrison M, Alotaibi MI, Carbajal KA, Alhadeff AL, Perron IJ, Yao R, Purdy CS, DeFelice DM, Wakai MH, Tomasiewicz J, Lin A, Meyer E, Peng Y, Arriola Apelo SI, Puglielli L, Betley JN, Paschos GK, Baur JA, Lamming DW. Chellappa K, et al. Among authors: purdy cs. Aging Cell. 2019 Oct;18(5):e13014. doi: 10.1111/acel.13014. Epub 2019 Aug 1. Aging Cell. 2019. PMID: 31373126 Free PMC article.
Corrigendum to "Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis" [Gynecologic Oncology 162 (2021) 532-538].
Levinson K, Beavis AL, Purdy C, Rositch AF, Viswanathan A, Wolfson AH, Kelly MG, Tewari KS, McNally L, Guntupalli SR, Ragab O, Lee YC, Miller DS, Huh WK, Wilkinson KJ, Spirtos NM, Le LV, Casablanca Y, Holman LL, Waggoner SE, Fader AN. Levinson K, et al. Among authors: purdy c. Gynecol Oncol. 2021 Dec;163(3):616-617. doi: 10.1016/j.ygyno.2021.09.017. Epub 2021 Oct 12. Gynecol Oncol. 2021. PMID: 34654574 Free PMC article. No abstract available.
A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Duska LR, Krasner CN, O'Malley DM, Hays JL, Modesitt SC, Mathews CA, Moore KN, Thaker PH, Miller A, Purdy C, Zamboni WC, Lucas AT, Supko JG, Schilder RJ. Duska LR, et al. Among authors: purdy c. Gynecol Oncol. 2021 Mar;160(3):688-695. doi: 10.1016/j.ygyno.2020.12.025. Epub 2020 Dec 31. Gynecol Oncol. 2021. PMID: 33390325 Clinical Trial.
The spirochete and multiple sclerosis.
NEWMAN HW, PURDY C, RANTZ L, HILL FC Jr. NEWMAN HW, et al. Among authors: purdy c. Calif Med. 1958 Dec;89(6):387-9. Calif Med. 1958. PMID: 13608292 Free PMC article.
98 results